(Q34074678)

30 July 2017

1 reference

title

IL-1 inhibitors: novel agents in the treatment of rheumatoid arthritis (English)

1 reference

30 July 2017

1 reference

Gabay C

1

1 reference

PubMed ID

11060665

30 July 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

Expert Opinion on Investigational Drugs

30 July 2017

1 reference

30 July 2017

9

1 reference

30 July 2017

1

1 reference

30 July 2017

113-127

1 reference

Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint

30 July 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.113

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.113

cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.113

Cloning and characterization of a new isoform of the interleukin 1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.113

Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.113

The human intracellular interleukin 1 receptor antagonist promoter appropriately regulates gene expression in keratinocytes and gastrointestinal epithelial cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.113

Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.113

Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.113

Interleukin-1 receptor antagonist: role in biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.113

Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.113

An interleukin 1 inhibitor affects both cell-associated interleukin 1-induced T cell proliferation and PGE2/collagenase production by human dermal fibroblasts and synovial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.113

Inhibition of interleukin-1-induced synovitis and articular cartilage proteoglycan loss in the rabbit knee by recombinant human interleukin-1 receptor antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.113

Adenoviral-mediated gene transfer to rabbit synovium in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.113

Inhibition of interleukin-1-induced effects in synoviocytes transduced with the human IL-1 receptor antagonist cDNA using an adenoviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.113

Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.113

Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.113

Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.113

Transplantation of transduced chondrocytes protects articular cartilage from interleukin 1-induced extracellular matrix degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.113

In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.113

Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.113

Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.113

Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.113

Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.113

Effects of methotrexate on differentiation of monocytes and production of cytokine inhibitors by monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.113

Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.113

The type II 'decoy' receptor: a novel regulatory pathway for interleukin 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.113

The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.113

AF12198, a novel low molecular weight antagonist, selectively binds the human type I interleukin (IL)-1 receptor and blocks in vivo responses to IL-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.113

Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.113

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.113

Manipulation of distinct NFkappaB proteins alters interleukin-1beta-induced human rheumatoid synovial fibroblast prostaglandin E2 formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.113

Defining therapeutic targets by using adenovirus: blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.113

Constitutive c-fos expression in osteoblastic MC3T3-E1 cells stimulates osteoclast maturation and osteoclastic bone resorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.113

Studies on the contribution of c-fos/AP-1 to arthritic joint destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.113

IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.113

Interleukin-1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.113

Interleukin-10 inhibition of the progression of established collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.1.113

21 January 2018

Identifiers

DOI

10.1517/13543784.9.1.113

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2y5rcll5nfbr5o2syzokiprtqm

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_2y5rcll5nfbr5o2syzokiprtqm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2y5rcll5nfbr5o2syzokiprtqm

mapped directly with Wikidata item

30 July 2022

based on heuristic

1 reference

https://api.fatcat.wiki/v0/release/2y5rcll5nfbr5o2syzokiprtqm